Trial intelligence / Profile preview

Dose Ranging Study of HDM SLIT Tablets in Allergic Asthma

NCT01930461Phase 2Completed

Sponsor
Stallergenes Greer
Start
Sep 2013
Primary completion
Jun 2015
Modality
Allergy Immunotherapy
Countries
3
01

Overview

A Phase 2 trial of House dust mite allergen extract in asthma, sponsored by Stallergenes Greer. Started Sep 2013; status: completed.

02

Drugs

House dust mite allergen extract
03

Conditions

asthma

Beyond the preview

Go deeper on NCT01930461.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT01930461.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call